HFNC optimizes respiratory management in children's painless gastroscopic diagnosis and treatment

Effect of HFNC on the incidence of hypoxemia in children's painless gastroscopic diagnosis and treatment

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060799

Enrollment

Unknown

Registered

2022-06-12

Start date

2022-06-01

Completion date

Unknown

Last updated

2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superficial gastritis

Interventions

Test group:High-flow nasal cannula oxygen therapy

Control group:Nasal cannula oxygen therapy

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Children who are electively undergoing gastroscopy under intravenous anesthesia; 2. Aged 6-12 years; 3. with a BMI of 18-25 kg/m2; 4. ASA grades I-II; 5. Parents or guardians agree to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Those with severe liver, kidney and respiratory diseases; 2. Those with a history of allergies to anesthetics; 3. Those with deviated nasal septum or other nasal anatomy abnormalities; 4. Those with obstructive sleep apnea syndrome.

Design outcomes

Primary

Measure	Time frame
Oxygen saturation;Incidence of hypoxemia;Transcutaneous carbon dioxide value;	—

Secondary

Measure	Time frame
Average arterial blood pressure;heart rate;	—

Countries

China

Contacts

Public ContactFang Chen

Shenzhen Children's Hospital

18938690929@163.com+86 18938690929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026